Developing a Psychosexual Educational Partners Program: PEPP A Feasibility Study
2 other identifiers
interventional
18
1 country
1
Brief Summary
This is a single arm study to evaluate the feasibility, adherence, and usefulness of a psychosexual education partner program (PEPP) to improve partner communication and sexual function. This study is intended to get initial input from a small group of up to 10 women and their partners about the appropriateness, usefulness, and critical nature of the content as well as the feasibility and appeal of the method of delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Mar 2022
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2021
CompletedFirst Posted
Study publicly available on registry
October 7, 2021
CompletedStudy Start
First participant enrolled
March 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 29, 2022
CompletedFebruary 13, 2023
February 1, 2023
6 months
September 21, 2021
February 10, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Attrition rate (feasibility)
After completion of each module the interventionist will contact patients and their partners by phone and document completion of the module's exercise. Anyone who does not provide data both before and after completing the surveys for the study will be considered to be prematurely withdrawn and included in the attrition count. The intervention will be considered feasible if the attrition rate is 25% or less at week 6 (+2 weeks). Withdrawal reasons will be captured and reported by category.
Week 6 (+2 weeks)
Secondary Outcomes (5)
Home practice rate (acceptability)
Week 6 (+2 weeks)
Participant experience assessed using Thematic Analysis
Week 6 (+2 weeks)
Impact of intervention, measured by Dyadic Sexual Communication (DSC)
Baseline to week 6 (+2 weeks)
Impact of intervention, measured by PROMIS® Sexual Function and Satisfaction V2.0 (PROMIS SexF V2)
Baseline to week 6 (+2 weeks)
Impact of intervention, measured by Revised Dyadic Adjustment Scale (RDAS)
Baseline to week 6 (+2 weeks)
Study Arms (1)
Psychosexual Educational Partners Program (PEPP)
EXPERIMENTALWomen and their partners will work through a three module workbook together, completing each module over a 2-week period (6 weeks total).
Interventions
A communication and intimacy promotion kit consisting of three modules devoted to information sharing, partner communication and activities for building intimacy.
Eligibility Criteria
You may qualify if:
- Age ≥18 female with a history of any stage breast and/or gynecological cancer.
- Completed primary treatment (chemotherapy, radiation and/or surgery) ≥ 3 months and ≤ 5 years prior to registration.
- May use concurrent adjuvant endocrine therapy or HER2-targeted therapy while on study.
- Responds yes to the question "Has there been change in communication and/or intimacy with your partner since your cancer diagnosis?"
- Ability to read and write English.
- A stable partner, defined as anyone with whom the woman has had an intimate relationship with for at least 3 months prior to her cancer diagnosis.
- Both partner and woman must agree to participate in the study and sign informed consent to the study.
You may not qualify if:
- Antidepressants are allowed if a person has been on them for 30 days prior to registration, and dose or treatment is not expected to change.
- Past history of sexual abuse.
- Psychiatric disorder such as major depressive disorder, bipolar disorder, obsessive compulsive disorder or schizophrenia. (Defined per medical history and/or patient self-report.)
- Currently enrolled in another study that addresses sexual health (enrollment in other clinical trials will be allowed).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48109, United States
Related Publications (1)
Arring NM, Reese JB, Lafferty C, Barton DL, Carter J. A Sexual Health Self-Management Intervention (Psychosexual Educational Partners Program) for Couples With a History of Breast and Gynecological Cancer: Mixed Methods Feasibility Study. JMIR Form Res. 2025 Oct 21;9:e75743. doi: 10.2196/75743.
PMID: 41118642DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Noel Arring, DNP, PhD, RN, OCN
University of Michigan Rogel Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2021
First Posted
October 7, 2021
Study Start
March 15, 2022
Primary Completion
August 29, 2022
Study Completion
August 29, 2022
Last Updated
February 13, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share